Astromech represents the strategic convergence of synthetic biology expertise with artificial intelligence development capabilities through the partnership of Ben Lamm and George Church. The venture ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback